Cargando…
Can Generic Intravenous Levetiracetam Be Used for Acute Repetitive Convulsive Seizure or Status Epilepticus? A Randomized Controlled Trial
INTRODUCTION: Intravenous levetiracetam (IV LEV) is approved for treatment status epilepticus (SE). However, the drug’s high cost must be considered when deciding on a treatment strategy. This study aimed to compare the efficacy of brand-name and generic IV LEV for acute repetitive convulsive seizur...
Autores principales: | Wongjirattikarn, Rachot, Sawanyawisuth, Kittisak, Pranboon, Sineenard, Tiamkao, Siriporn, Tiamkao, Somsak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858918/ https://www.ncbi.nlm.nih.gov/pubmed/31407191 http://dx.doi.org/10.1007/s40120-019-00150-x |
Ejemplares similares
-
The Efficacy and Safety Profile of Generic Intravenous Levetiracetam in a Real-World Setting
por: Ruangritkul, Preechaya, et al.
Publicado: (2021) -
Adjunctive enteral phenobarbital for adult status epilepticus: a brief report
por: Tiamkao, Somsak, et al.
Publicado: (2013) -
Prevalence of factors associated with poor outcomes of hospitalized myasthenia gravis patients in Thailand
por: Tiamkao, Somsak, et al.
Publicado: (2014) -
Factors predicting the outcomes of elderly hospitalized myasthenia gravis patients: a national database study
por: Tiamkao, Somsak, et al.
Publicado: (2017) -
Clinical outcomes of intravenous levetiracetam treatment in patients with renal impairment
por: Lapmag, Anyamanee, et al.
Publicado: (2018)